pentamidine has been researched along with Infection, Mycobacterium avium-intracellulare in 10 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevention of cerebral toxoplasmosis and of Pneumocystis carinii pneumonia is an essential objective in the management of patients infected with HIV." | 2.68 | Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients. ( Carles, M; Dellamonica, P; Durant, J; Hazime, F; Pechere, JC, 1995) |
| "Pneumocystis carinii pneumonia is the most common infection and also one of the most readily treatable illnesses that these patients encounter." | 2.38 | Outpatient diagnosis and treatment of AIDS-related pulmonary infections. ( Polnitsky, CA; Sherter, CB, 1989) |
| "carinii prophylaxis before the onset of AIDS: Mycobacterium avium complex disease, which developed in 33." | 1.29 | Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. ( Anderson, R; Bacellar, H; Detels, R; Hoover, DR; Kaslow, RA; Phair, J; Saah, AJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 9 (90.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opravil, M | 1 |
| Pechère, M | 1 |
| Lazzarin, A | 1 |
| Heald, A | 1 |
| Rüttimann, S | 1 |
| Iten, A | 1 |
| Furrer, H | 1 |
| Oertle, D | 1 |
| Praz, G | 1 |
| Vuitton, DA | 1 |
| Durant, J | 1 |
| Hazime, F | 1 |
| Carles, M | 1 |
| Pechere, JC | 1 |
| Dellamonica, P | 1 |
| Cabié, A | 1 |
| Matheron, S | 1 |
| Khuong, MA | 1 |
| Bouchaud, O | 1 |
| Saimot, AG | 1 |
| Coulaud, JP | 1 |
| Hoover, DR | 1 |
| Saah, AJ | 1 |
| Bacellar, H | 1 |
| Phair, J | 1 |
| Detels, R | 1 |
| Anderson, R | 1 |
| Kaslow, RA | 1 |
| Anastasi, JK | 1 |
| Rivera, J | 1 |
| Sackoff, J | 1 |
| McFarland, J | 1 |
| Su, S | 1 |
| Bryan, E | 1 |
| Cheng, B | 1 |
| Hardy, WD | 1 |
| Polnitsky, CA | 1 |
| Sherter, CB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentamidine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Outpatient diagnosis and treatment of AIDS-related pulmonary infections.
Topics: Acquired Immunodeficiency Syndrome; Ambulatory Care; Cytomegalovirus Infections; Humans; Mycobacteri | 1989 |
4 trials available for pentamidine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Digestive System; Drug Therapy, Combinati | 1995 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agent | 1998 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
5 other studies available for pentamidine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Dapsone as prophylaxis for disseminated Mycobacterium avium complex infection.
Topics: Dapsone; Humans; Mycobacterium avium-intracellulare Infection; Pentamidine; Retrospective Studies; T | 1995 |
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Candidiasis; CD4-Positive | 1993 |
Understanding prophylactic therapy for HIV infections.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cytomegalovirus Infections; Dru | 1994 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |